Masoud Toloue

Masoud offers a wealth of industry experience and a high-growth track record to Quanterix. He has led the scaling of both small private and larger publicly traded companies and commercialized disruptive technologies in each of them. He joined Quanterix from PerkinElmer, where he most recently served as Senior Vice President, Diagnostics, growing the business unit to over fifty percent of the company’s total revenue. He previously led that company’s Applied Genomics business. Prior to this role, he founded and led Bioo Scientific’s next-generation sequencing business which was acquired by PerkinElmer in 2016. He also co-founded and led Genohub, where he transformed that company from a supplier of next-generation sequencing matching technology to a leading platform provider for managing sequencing projects globally.

Masoud holds a doctoral degree in molecular cell biology from the University at Buffalo and was a postdoctoral fellow in protein biochemistry at The University of Texas Health Science Center at San Antonio.